Back to all studies
CompletedNCT05813080

Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders

This study is completed. It focuses on schizophrenia and currently lists study information in Germany.

Schizophrenia, PreventionDeviceFrom 16 Years to 40 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

Need help deciding?

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT05813080. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

Check the official registry

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Germany · 21 sites
  • ZfP Reichenau - Akademisches Lehrkrankenhaus Universität Konstanz
    Konstanz, Baden-Wurttemberg
    Site status: Not listed — confirm with the team
  • Zentralinstitut für Seelische Gesundheit
    Mannheim, Baden-Wurttemberg
    Site status: Not listed — confirm with the team
  • Klinik für Psychiatrie und Psychotherapie Universität Tübingen
    Tübingen, Baden-Wurttemberg
    Site status: Not listed — confirm with the team
  • Bezirkskrankenhaus Augsburg, Klinik für Psychiatrie, Psychotherapie und Psychosomatik der Universität Augsburg
    Augsburg, Bavaria
    Site status: Not listed — confirm with the team
  • Klinikum der Ludwig-Maximilians-Universität München
    München, Bavaria
    Site status: Not listed — confirm with the team
  • Zentrum für psychische Gesundheit, U11iversitätsklinikum Würzburg
    Würzburg, Bavaria
    Site status: Not listed — confirm with the team
  • Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf {UKE)
    Hamburg, Free and Hanseatic City of Hamburg
    Site status: Not listed — confirm with the team
  • Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Universitätsklinikum Aachen, RWTH Universität Aachen
    Aachen, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • LWL-Universitätsklinikum Bochum der Ruhr--Universität Bochum, Klinik für Psychiatrie, Psychotherapie und Präventivmedizin
    Bochum, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • KJPP LVR-Klinik Bonn
    Bonn, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • Universitätsklinikum Bonn Klinik für Psychiatrie und Psychotherapie
    Bonn, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • Uniklinik Köln, Klinik und Poliklin-ik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters
    Cologne, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • Klinik und Poliklinik für Psychiatrie und Psychotherapie Heinrich-Heine-Universität Düsseldorf
    Düsseldorf, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • Institut für Translationale Psychiatrie
    Münster, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • Rheinhessen Fachklinik Alzey
    Alzey, Rhineland-Palatinate
    Site status: Not listed — confirm with the team
  • UKD Dresden, Klinik und Poliklinik für Psychiatrie und Psychotherapie
    Dresden, Saxony
    Site status: Not listed — confirm with the team
  • Otto-von-Guericke- Universität Magdeburg
    Magdeburg, Saxony-Anhalt
    Site status: Not listed — confirm with the team
  • Zentrum für Integrative Psychiatrie Kiel
    Kiel, Schleswig-Holstein
    Site status: Not listed — confirm with the team
  • Zentrum für Integrative Psychiatrie (ZIP) und Fachklinik für Junges Leben (JuLe) Kinder- und Jugendpsychiatrie
    Lübeck, Schleswig-Holstein
    Site status: Not listed — confirm with the team
  • Vivantes Klinikum Am Urban
    Berlin, State of Berlin
    Site status: Not listed — confirm with the team
  • Charité - Universitätsmedizin Berlin
    Berlin, State of Berlin
    Site status: Not listed — confirm with the team
In plain English

Key information made simple

What is this study testing?

This study is testing whether "pronia.ai" medical device for high risk psychosis prognosis may be useful for people experiencing schizophrenia.

What would participation involve?

Participants may use "pronia.ai" medical device for high risk psychosis prognosis, attend study visits with the research team. The registry lists locations in Germany.

Who is it mainly for?

This study appears to be mainly for people with schizophrenia.

What should you check before joining?

Ask about whether participation can be remote and what device access is needed, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: May 1, 2023
Recruitment status
Completed
Enrollment listed in the registry
260
Sponsor
Heinrich-Heine University, Duesseldorf
Sponsor type
University
Study type
Device
Intervention type
DEVICE, OTHER
Study phase
Not clearly listed
Locations
Germany
Age range
From 16 Years to 40 Years
Official registry ID
NCT05813080
Official title
Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders
Official source
Official registry link

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT05813080. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medical device for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study involving "pronia.ai" medical device for high risk psychosis prognosis, Treatment-as-usual (TAU). The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 16 Years to 40 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about data, monitoring, alerts, and daily use?

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Heinrich-Heine University, Duesseldorf, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me